# About Script CJC-1295

> Script CJC-1295 is an independent editorial project that reads and summarizes the peer-reviewed and regulatory record on CJC-1295. We are not a clinic, not a pharmacy, and not a prescriber.

An independent editorial reading of one compound's published record. No clinic, no pharmacy, no prescriber.

## What this site is

Script CJC-1295 is an independent editorial project that publishes summaries of the peer-reviewed research literature and the public regulatory record on CJC-1295. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The domain name contains the word "script" because that is the search term real readers type when they want to know whether a doctor can write a prescription for the peptide. The word frames a *question*, not a *service*. This site does not write prescriptions and does not refer to anyone who does. It reads the regulatory record carefully and reports what it says, including the parts where the answer is "no" or "not yet."

## How we source

Every quantitative claim on this site is traceable to a primary source listed on the **References** page. We prefer peer-reviewed journals (the Teichman 2006 Phase 1 PK paper; the Alba 2006 GHRH-knockout mouse work; the Jetté 2005 identification paper; the Ionescu 2006 pulsatility paper; the Sackmann-Sala 2009 proteomic substudy), government and intergovernmental records (FDA Drugs@FDA, the FDA-2024-N-4777 docket and its October and December 2024 PCAC briefing materials, the January 2025 final interim 503A guidance, the WADA 2025 Prohibited List, ClinicalTrials.gov NCT00267527), and the original ConjuChem-era development record where it remains publicly accessible.

When the public record is incomplete — the Phase 2 trial primary endpoint data, for example, were never published after the October 2006 trial termination — we say so. When a regulatory event is an announcement rather than a binding rule — the February 27, 2026 HHS Joe Rogan statement, for example — we say that too. The distinction between "announced" and "finalized" matters in pharmaceutical regulation, and we keep it visible.

## What we do not do

We do not prescribe. We do not refer. We do not sell. We do not link to vendors. We do not publish dosing recommendations for any human exposure. We do not invent staff and we do not claim a physical location or clinical capacity. The voice-first design vocabulary of this site — transcript bubbles, spectrograms, listening pulses — is editorial framing for a question-and-answer architecture, not a representation that this site provides any service.

The word "script" in the domain name is editorial framing — a position the publisher occupies relative to the literature, not a claim about the site's services.

---

An independent editorial reading of publicly available research — not a clinic, not a prescriber, not a vendor.